Vestmark Advisory Solutions, Inc.
- SEC CIK
- 0001736982
- Latest filing
- Aug 14, 2026
RXRX holding history
Recursion Pharmaceuticals, Inc. in every 13F filed by Vestmark Advisory Solutions, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RXRX overviewAll 13F holders of RXRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 708,858
- Value
- $2.60M
- % of portfolio
- <0.1%
- Quarters held
- 11
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 708,858 | $2.60M | <0.1% | −18,128−2.5% | Reduced | Holders |
| Q1 2026 | 726,986 | $2.23M | <0.1% | +122,230+20.2% | Added | Holders |
| Q4 2025 | 604,756 | $2.47M | <0.1% | −16,303−2.6% | Reduced | Holders |
| Q3 2025 | 621,059 | $3.03M | 0.1% | −718,080−53.6% | Reduced | Holders |
| Q2 2025 | 1,339,139 | $6.78M | 0.1% | +632,900+89.6% | Added | Holders |
| Q1 2025 | 706,239 | $3.74M | 0.1% | −138,915−16.4% | Reduced | Holders |
| Q4 2024 | 845,154 | $6.36M | 0.2% | +112,221+15.3% | Added | Holders |
| Q3 2024 | 732,933 | $4.83M | 0.2% | −51,964−6.6% | Reduced | Holders |
| Q2 2024 | 784,897 | $5.89M | 0.2% | −115,122−12.8% | Reduced | Holders |
| Q1 2024 | 900,019 | $8.97M | 0.4% | +427,763+90.6% | Added | Holders |
| Q4 2023 | 472,256 | $4.66M | 0.2% | +472,256 | New | Holders |